CONTINUE TO SITE ➞

Don't miss tomorrow's biopharma industry news

Let BioPharma Dive's free newsletter keep you informed, straight from your inbox.

Daily Dive M-F

Commercialization Weekly Every Wednesday

Gene Therapy Weekly Every Thursday

Emerging Biotech Weekly Every Tuesday

By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

Deep Dive
Library
Events
Press Releases

Pharma
Biotech
FDA
Clinical Trials
Deals
Drug Pricing
Gene Therapy

What We're Reading: Page 342

Industry reads hand-picked by our editors

Nov 16, 2015

Stat News
Celebrity selfies, lax regulations drive boom in supplements
Reuters
WHO: Misunderstanding of antibiotics fuels superbug threat
in-PharmaTechnologist
As Philidor closes, Valeant tries to shake off ties

Nov 13, 2015

Reuters
Reuters: Valeant played a key role in building, operating Philidor RX
Stat News
Brain scans could predict recovery from coma
FierceBiotech
Promise of in vivo drug production sets off an mRNA arms race
Boston Globe
Biogen making risky shift to Alzheimer’s drugs

Nov 12, 2015

Stat News
Inside the drive to collect DNA from 1 million veterans and revolutionize medicine
Japan Times
Gene therapy helps teens with rare genetic disorder
WSJ
Mylan hostile takeover bid for Perrigo a rare nail biter

Nov 11, 2015

FierceBiotech
Sophiris' prostate drug stages a Phase III comeback after a grim prognosis
Reuters
Drug industry bemoans Britain's lack of science skills
Japan Times
Novartis Japan faces censure for delay in disclosing drug side effects

Nov 10, 2015

FierceBiotech
Astellas offers $379M buyout for a pioneering stem cell survivor
Seeking Alpha
Lawsuit accuses Sanofi of stalling MS drug to avoid $708M in payments
in-PharmaTechnologist
Three Dr. Reddy's sites hit with warning letters in India

Nov 09, 2015

Reuters
Advising people about heart risk genes helped cut cholesterol: study
Pharma Times
End of the road for British Off-Patent Drugs bill
WSJ
U.S. Targets Pharmacies Over Soaring Claims to Military Health Program

Nov 06, 2015

Bloomberg
Martin Shkreli Responds to Hillary Clinton's Latest Twitter Swipe: LOL
Reuters
Allergan CEO Saunders warms up to drug discovery
NBC News
The Painkiller: A Drug Company Putting Profits Above Patients

Previous Next

Get the free newsletter

Subscribe to BioPharma Dive for top news, trends & analysis

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.

Library resources

Industry Report
CGT Commercialization: Tackling Barriers to Market Success Custom content for Cencora
Playbook
Centralized Clinical Trial Recruitment: A Strategic Plan Custom content for WCG
Trendline
Inside the growing treatment market for rare diseases Supported by Advanced Clinical

View all

Company Announcements

View all | Post a press release

Events

View all | Promote an event

Industry Intel

Evolving Regulatory Landscape for Model Informed Drug Development (MIDD): Impact of the Draft ICH M15 Guidance Webinar - on demand • Provided by Certara
Top Ways that AI Will Change Life Sciences Webinar - on demand • Provided by Salesforce
Understanding Publication Impact and Engagement with Data and AI-Driven Solutions Webinar - on demand • Provided by Altmetric

Explore

About
Editorial Team
Contact Us
Newsletter
Purchase Licensing Rights
Press Releases
What We're Reading

Reach our audience

Advertising
Post a press release
Promote an event

Related Publications

Healthcare Dive
MedTech Dive

Industry Dive is an Informa TechTarget business.

This website is owned and operated by Informa TechTarget, part of a global network that informs, influences and connects the world's technology buyers and sellers. All copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. TechTarget, Inc.'s registered office is 275 Grove St. Newton, MA 02466.

Home
- Pharma
- Biotech
- FDA
- Clinical Trials
- Deals
- Drug Pricing
- Gene Therapy
Deep Dive
Library
Events
Press Releases

Get BioPharma Dive in your inbox

The free newsletter covering the top industry headlines

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.